• Return to Headlines

Amgen Inc (AMGN) Approaches New Upside Target of $191.94

By David Diaz

Shares of Amgen Inc (NASDAQ:AMGN) have bullishly opened above the pivot of $189.74 today and have reached the first resistance level of $190.84. Investors may be interested in a cross of the next upside pivot targets of $191.94 and $194.14.

Over the past year, Amgen Inchas traded in a range of $0.00 to $201.23 and are now at $0.00. The 200-day and 50-day moving averages have moved 0.1% lower and 0.40% higher over the past week, respectively.

There is potential upside of 0.0% for shares of Amgen Inc based on a current price of $0.00 and an average consensus analyst price target of $196.19. Amgen Inc shares should first meet resistance at the 50-day moving average (MA) of $152.63 and find additional resistance at the 200-day MA of $154.90.

SmarTrend recommended that subscribers consider buying shares of Amgen Inc on February 15th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $182.45. Since that recommendation, shares of Amgen Inc have risen 4.0%. We continue to monitor AMGN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: pivot alerts amgen inc

Ticker(s): AMGN